Wall Street Zen Upgrades KORU Medical Systems (NASDAQ:KRMD) to “Strong-Buy”

KORU Medical Systems (NASDAQ:KRMD) was upgraded by investment analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Monday.

Several other research firms have also recently commented on KRMD. Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Wednesday, October 8th. Lake Street Capital increased their price objective on shares of KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a report on Monday, December 22nd. Finally, Canaccord Genuity Group boosted their target price on KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $5.88.

KORU Medical Systems Price Performance

Shares of KRMD opened at $5.65 on Monday. KORU Medical Systems has a one year low of $1.86 and a one year high of $6.61. The stock’s fifty day moving average is $5.30 and its 200-day moving average is $4.38. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.92 and a current ratio of 2.48. The firm has a market capitalization of $261.71 million, a price-to-earnings ratio of -70.63 and a beta of 0.51.

Institutional Investors Weigh In On KORU Medical Systems

A number of institutional investors and hedge funds have recently modified their holdings of KRMD. Police & Firemen s Retirement System of New Jersey purchased a new stake in KORU Medical Systems in the 2nd quarter worth about $30,000. BNP Paribas Financial Markets grew its stake in KORU Medical Systems by 52.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after acquiring an additional 3,478 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of KORU Medical Systems in the 2nd quarter valued at about $59,000. Acadian Asset Management LLC acquired a new position in shares of KORU Medical Systems in the 1st quarter valued at about $63,000. Finally, Intech Investment Management LLC purchased a new stake in shares of KORU Medical Systems in the second quarter worth approximately $73,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.